Matinas BioPharma Holdings (MTNB) Non Operating Income (2013 - 2026)
Matinas BioPharma Holdings' Non Operating Income was $155,093 in Q3 2020, down 1.1% from $156,872 a year earlier and down 0.6% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Non Operating Income (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Matinas BioPharma Holdings' Non Operating Income was $701,572 through Sep 30, 2020, up 70.5% year-over-year; for FY2019, it was $541,303, up 857.2% from FY2018.
- In earlier years, Non Operating Income was $56,552 in FY2018 (+156.7%), $22,032 in FY2017, -$16,505 in FY2016 and $19,627 in FY2015.
- The Q3 2020 figure marks the lowest quarterly Non Operating Income since Q1 2019.
- Compared with a year earlier, Non Operating Income was higher in five of the last seven quarters, with growth averaging 303.9%.
- The best year-over-year quarter for Non Operating Income over five years was Q3 2019 (growth of 740.7%); the worst was Q2 2020 (a decline of 7.6%).
- Per Business Quant data, MTNB's Non Operating Income in the three quarters before Q3 2020 was $156,000 (Q2 2020), $227,327 (Q1 2020) and $163,152 (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Matinas BioPharma Holdings | 508,224.03 | -12.08 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Sep 30, 2020 | 155,093.00 |
| Jun 30, 2020 | 156,000.00 |
| Mar 31, 2020 | 227,327.00 |
| Dec 31, 2019 | 163,152.00 |
| Sep 30, 2019 | 156,872.00 |
| Jun 30, 2019 | 168,872.00 |
| Mar 31, 2019 | 52,407.00 |
| Dec 31, 2018 | 33,248.00 |
| Sep 30, 2018 | 18,660.00 |
| Jun 30, 2018 | -6,101.00 |
| Mar 31, 2018 | 10,745.00 |
| Dec 31, 2017 | 8,678.00 |
| Sep 30, 2017 | 13,584.00 |
| Jun 30, 2017 | 8,663.00 |
| Mar 31, 2017 | -8,893.00 |
| Dec 31, 2016 | -2,402.00 |
| Sep 30, 2016 | -3,325.00 |
| Jun 30, 2016 | -3,656.00 |
API Access
Matinas BioPharma Holdings Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();